I am pleased to be part of the roundtable panel, “Update on State and Federal Enforcement Initiatives,” at the American Conference Institute’s Summit on Controlled Substances, being held January 29-31 at the Washington Plaza Hotel in Washington, D.C.

Conference faculty will discuss current challenges, benchmark strategies, and how to prepare for the future of this critical and fast-paced industry. Hear from:

  • Current and former DEA attorneys
  • Current and former FDA attorneys
  • State and U.S. attorneys
  • In-House Counsel
  • Top law firm counsel

Topics include:

  • Reassessing Your Responsibilities in Light of the Changing Scope of Suspicious Order Monitoring Requirements
  • Evolution of Abuse-Deterrent Opioid Drug Products
  • Understanding and Comparing State Prescription Drug Monitoring Programs
  • Diving Into State, County, and City Opioid-Related Investigations

Register today and use the code P10-999-DEA18 to receive a discount on registration fees.